.Pharmacolibrary.Drugs.ATC.L.L01XX35

Information

name:Anagrelide
ATC code:L01XX35
route:oral
compartments:2
dosage:1mg
volume of distribution:20L
clearance:30L/h
other parameters in model implementation

Anagrelide is a phosphodiesterase 3 (PDE3) inhibitor used for the treatment of essential thrombocythemia (ET) to reduce elevated platelet counts and the risk of thrombosis. It is approved and utilized clinically for this indication.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adults and patients with essential thrombocythemia after oral administration.

References

    Revisions


    Generated at 2025-08-10T18:21:06Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos